After a number of positive referals, Sound Bioventures decided to hire Andulf Advokater with Anders Apell and Ulf Edebrink, as their legal representatives. Anders and Ulf where part of founding Andulf Advokater, back in 2004, and specializes in private equity, venture capital and real estate fund formation. Johan Kördel commented: “Others had told us that Anders and Ulf have superb and strategic legal minds – Boy can we underwrite that! We are so happy to have them on our side. Experienced and efficient – they cut to the chase”
Sound Bioventures Works with Andulf Advokater
The oral therapeutic that could change our approach to retinal disease. An inflammation-based view of both ophthalmic and neurologic health
Dr Burian said oral therapies can also function in conjunction with therapies currently on the market. In late July, biotech incubator Golgi Neurosciences S.r.l. and biopharmaceutical company Breye Therapeutics ApS announced their collaboration to develop the P2X7 receptor antagonist programme. Breye Therapeutics, a clinical-stage pharmaceutical co ...
From Doctor To Investor: How My MBA Kickstarted An Exciting Career In Life Sciences Venture Capital
Aiming to make an impact in his career, certified medical doctor Philip Brainin combined his healthcare expertise with an MBA to launch a career in life sciences venture capital A keen interest in learning and a desire to help others have defined Philip Brainin’s career so far. Today he is an analyst with a specialist […]
Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence
Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 – Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage private companies in Europe and the USA developing specialty therapeutics, today announced that Fredrik Lehmann, Ph.D., MBA has joined the company as its first Entrepreneur-in-Residence. Fr ...
At the intersection of entrepreneurship, life science, & patient needs
Fredrik Lehmann, Entrepreneur in Residence at Sound Bioventures, explains how success in life science takes tenacity and constant focus on patient needs.